193 related articles for article (PubMed ID: 30391288)
1. Phenotypic and molecular features underlying neurodegeneration of motor neurons derived from spinal and bulbar muscular atrophy patients.
Sheila M; Narayanan G; Ma S; Tam WL; Chai J; Stanton LW
Neurobiol Dis; 2019 Apr; 124():1-13. PubMed ID: 30391288
[TBL] [Abstract][Full Text] [Related]
2. Exercise attenuates polyglutamine-mediated neuromuscular degeneration in a mouse model of spinal and bulbar muscular atrophy.
Hirunagi T; Nakatsuji H; Sahashi K; Yamamoto M; Iida M; Tohnai G; Kondo N; Yamada S; Murakami A; Noda S; Adachi H; Sobue G; Katsuno M
J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):159-172. PubMed ID: 37937369
[TBL] [Abstract][Full Text] [Related]
3. X-Linked Spinal and Bulbar Muscular Atrophy: From Clinical Genetic Features and Molecular Pathology to Mechanisms Underlying Disease Toxicity.
Cortes CJ; La Spada AR
Adv Exp Med Biol; 2018; 1049():103-133. PubMed ID: 29427100
[TBL] [Abstract][Full Text] [Related]
4. Mid1 is associated with androgen-dependent axonal vulnerability of motor neurons in spinal and bulbar muscular atrophy.
Ogura Y; Sahashi K; Hirunagi T; Iida M; Miyata T; Katsuno M
Cell Death Dis; 2022 Jul; 13(7):601. PubMed ID: 35821212
[TBL] [Abstract][Full Text] [Related]
5. In Vitro and In Vivo Modeling of Spinal and Bulbar Muscular Atrophy.
Pennuto M; Basso M
J Mol Neurosci; 2016 Mar; 58(3):365-73. PubMed ID: 26614347
[TBL] [Abstract][Full Text] [Related]
6. Stem cell-derived motor neurons from spinal and bulbar muscular atrophy patients.
Grunseich C; Zukosky K; Kats IR; Ghosh L; Harmison GG; Bott LC; Rinaldi C; Chen KL; Chen G; Boehm M; Fischbeck KH
Neurobiol Dis; 2014 Oct; 70():12-20. PubMed ID: 24925468
[TBL] [Abstract][Full Text] [Related]
7. X-linked SBMA model mice display relevant non-neurological phenotypes and their expression of mutant androgen receptor protein in motor neurons is not required for neuromuscular disease.
Gromova A; Cha B; Robinson EM; Strickland LM; Nguyen N; ElMallah MK; Cortes CJ; La Spada AR
Acta Neuropathol Commun; 2023 Jun; 11(1):90. PubMed ID: 37269008
[TBL] [Abstract][Full Text] [Related]
8. Deterioration of muscle force and contractile characteristics are early pathological events in spinal and bulbar muscular atrophy mice.
Gray AL; Annan L; Dick JRT; La Spada AR; Hanna MG; Greensmith L; Malik B
Dis Model Mech; 2020 May; 13(5):. PubMed ID: 32152060
[TBL] [Abstract][Full Text] [Related]
9. Gene expression analysis reveals early dysregulation of disease pathways and links Chmp7 to pathogenesis of spinal and bulbar muscular atrophy.
Malik B; Devine H; Patani R; La Spada AR; Hanna MG; Greensmith L
Sci Rep; 2019 Mar; 9(1):3539. PubMed ID: 30837566
[TBL] [Abstract][Full Text] [Related]
10. Unveiling synapse pathology in spinal bulbar muscular atrophy by genome-wide transcriptome analysis of purified motor neurons derived from disease specific iPSCs.
Onodera K; Shimojo D; Ishihara Y; Yano M; Miya F; Banno H; Kuzumaki N; Ito T; Okada R; de Araújo Herculano B; Ohyama M; Yoshida M; Tsunoda T; Katsuno M; Doyu M; Sobue G; Okano H; Okada Y
Mol Brain; 2020 Feb; 13(1):18. PubMed ID: 32070397
[TBL] [Abstract][Full Text] [Related]
11. Neurotoxic effects of androgens in spinal and bulbar muscular atrophy.
Parodi S; Pennuto M
Front Neuroendocrinol; 2011 Oct; 32(4):416-25. PubMed ID: 21745497
[TBL] [Abstract][Full Text] [Related]
12. Brief report: phenotypic rescue of induced pluripotent stem cell-derived motoneurons of a spinal muscular atrophy patient.
Chang T; Zheng W; Tsark W; Bates S; Huang H; Lin RJ; Yee JK
Stem Cells; 2011 Dec; 29(12):2090-3. PubMed ID: 21956898
[TBL] [Abstract][Full Text] [Related]
13. Nucleic Acid-Based Therapeutic Approach for Spinal and Bulbar Muscular Atrophy and Related Neurological Disorders.
Hirunagi T; Sahashi K; Meilleur KG; Katsuno M
Genes (Basel); 2022 Jan; 13(1):. PubMed ID: 35052449
[TBL] [Abstract][Full Text] [Related]
14. An interdomain interaction of the androgen receptor is required for its aggregation and toxicity in spinal and bulbar muscular atrophy.
Orr CR; Montie HL; Liu Y; Bolzoni E; Jenkins SC; Wilson EM; Joseph JD; McDonnell DP; Merry DE
J Biol Chem; 2010 Nov; 285(46):35567-77. PubMed ID: 20826791
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy (SBMA).
Banno H; Katsuno M; Suzuki K; Tanaka F; Sobue G
Cell Tissue Res; 2012 Jul; 349(1):313-20. PubMed ID: 22476656
[TBL] [Abstract][Full Text] [Related]
16. [Clinical features of a genetically identified spinal and
bulbar muscular atrophy pedigree].
Wang Z; Chen Q; Li Q; Bi F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 41(10):1101-1105. PubMed ID: 27807335
[TBL] [Abstract][Full Text] [Related]
17. Molecular Mechanisms and Therapeutics for SBMA/Kennedy's Disease.
Arnold FJ; Merry DE
Neurotherapeutics; 2019 Oct; 16(4):928-947. PubMed ID: 31686397
[TBL] [Abstract][Full Text] [Related]
18. Spinal and Bulbar Muscular Atrophy Overview.
Fischbeck KH
J Mol Neurosci; 2016 Mar; 58(3):317-20. PubMed ID: 26547319
[TBL] [Abstract][Full Text] [Related]
19. Pre-clinical symptoms of SBMA may not be androgen-dependent: implications from two SBMA mouse models.
Xu Y; Halievski K; Katsuno M; Adachi H; Sobue G; Breedlove SM; Jordan CL
Hum Mol Genet; 2018 Jul; 27(14):2425-2442. PubMed ID: 29897452
[TBL] [Abstract][Full Text] [Related]
20. Beyond motor neurons: expanding the clinical spectrum in Kennedy's disease.
Manzano R; Sorarú G; Grunseich C; Fratta P; Zuccaro E; Pennuto M; Rinaldi C
J Neurol Neurosurg Psychiatry; 2018 Aug; 89(8):808-812. PubMed ID: 29353237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
